Hua Xue^1*, Jiangbo Zhang^1*, Jing Wang^1*, Songying Zhao^1*, Huimei Guo^1*, Jia Liu^1*, Jianmei Xu^1* and Yao Liu²

¹Affiliated Hospital of Hebei University, Baoding, China
²Chongqing University Cancer Hospital, Chongqing, China

Taylor Kujawa, PharmD^1*, Charlotte B Wagner, PharmD^2*, Alexis Riddle, RN^2*, Jordan Robeson, RN^2*, Laura Bickel, APRN^2*, Andrea Schindler, MHA, MSN, APRN, GNP-BC^2*, Srinivas K Tantravahi, MD² and Paul J. Shami, MD³

¹Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Millcreek, UT
²Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
³University of Utah Huntsman Cancer Institute, Salt Lake City, UT

David Fox^1*, Fadoua El Moustaid^1*, Anthony Masaquel^1*, Katherine L Rosettie^1*, Hazal Celik^2*, Lourenia Cassoli^1* and Christopher R. Flowers, MD, MS³

¹Genentech, Inc., South San Francisco, CA
²F. Hoffmann-La Roche Ltd, Basel, Switzerland
³MD Anderson Cancer Center, Houston, TX

David Elsea, MSc^1*, Josh J Carlson, PhD, MPH^2*, Benjamin Eckert, MS^3*, Anthony Hewitt, MBS^4* and Luciano J. Costa, MD, PhD⁵

¹Curta Inc, Las Vegas, NV
²CHOICE, University of Washington, Seattle, WA
³Adaptive Biotechnologies, Philadelphia, PA
⁴Adaptive Biotechnologies, Seattle, WA
⁵Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Vestavia, AL

Matthew Matasar, MD, MS¹, Katherine L Rosettie^2*, Shih-Wen Lin^2*, Mei Wu^2* and Esprit Ma^2*

¹Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ
²Genentech, Inc., South San Francisco, CA

Hannah Katz, PsyD^1*, Lauren N Scott^2*, Pilar Thangwaritorn, BS^3*, Jianzheng Wu^4*, William Wesson, MD, MPH⁵, Dinesh Pal Mudaranthakam, PhD^4*, Shaun DeJarnette^6*, Al-Ola Abdallah, MD⁷, Marc Hoffmann, MD⁸, Forat Lutfi, MD⁷, Sunil Abhyankar, MD⁷, Leyla O. Shune, MD⁶, Muhammad Umair Mushtaq⁷, Anurag Singh, MD^7*, Haitham Abdelhakim, MD⁹, Joseph P. McGuirk, DO¹⁰, Muhammad Mahdi Nashatizadeh, MD^6*, Liz Muenks, PhD^11* and Nausheen Ahmed, MD¹²

¹Department of Psychiatry and Behavioral Sciences, Univeristy of Kansas Medical Center, Westwood, KS
²US Myeloma Innovations Research Collaborative (USMIRC), Westwood
³University of Kansas, Lawrence, KS
⁴Department of Biostatistics, The University of Kansas Medical Center, Kansas City, KS
⁵School of Medicine, University of Kansas Medical Center, Kansas City, KS
⁶University of Kansas Medical Center, Kansas City, KS
⁷Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁸University of Kansas Cancer Center, Kansas City, KS
⁹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS
¹⁰University of Kansas Medical Center, Westwood, KS
¹¹Department of Psychiatry and Behavioral Sciences, Unversity of Kansas Medical Center, Kansas City
¹²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS

Adam S Kittai, MD¹, Dipen A. Patel, PhD^2*, Jason Shafrin, PhD^3*, Nadine Zawadzki, PhD, MPH^3*, Vikram Shetty, MD^2*, Khounish Sharma, BS^3*, Yazan K. Barqawi, PharmD, PhD, MS, MBA^2* and Joanna M. Rhodes, MD, MSCE^4*

¹Icahn School of Medicine at Mount Sinai, New York, NY
²AstraZeneca, Gaithersburg, MD
³FTI Consulting, Washington, DC
⁴Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Hamlet Gasoyan, PhD^1*, Faiz Anwer, MD², Jeffrey D. Kovach, MSc^3*, Nicholas J Casacchia, PharmD, MSc^1*, Ming Wang, PhD^4*, Jason Valent, MD² and Michael B. Rothberg, MD, MPH^1*

¹Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, OH
²Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
³Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
⁴Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH

Sameh Gaballa, MD¹, Manoj Khanal, Ph.D^2*, Yongmei Chen, M.S.^2*, Naleen Raj Bhandari, Ph.D^2*, Katherine B. Winfree^2*, Sarang Abhyankar, M.D.^2* and Lisa M. Hess, Ph.D^2*

¹Moffitt Cancer Center, Tampa, FL
²Eli Lilly and Company, Indianapolis, IN

Joseph Mikhael, MD, MeD, FRCPC, FACP¹, Cesar Rodriguez, MD^2*, Amy E. Pierre, MSN^3,4*, M. Sarfraz Nawaz, MD⁵, Ellie Moses-Okwei, PhD^6*, Lindsay Gurska, PhD^6*, Emily Zyborowicz, MPH^6*, Shelby Sullivan, PharmD^6*, Jeffrey Carter, PhD^6* and Cherilyn Heggen, PhD^6*

¹City of Hope Cancer Center, Translational Genomics Research Institute, Phoenix, AZ
²Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Flatiron Health, River Vale, NJ
⁵Hematology Oncology of Indiana, Indianapolis, IN
⁶PRIME Education, New York, NY

M. Sarfraz Nawaz, MD¹, Ellie Moses-Okwei, PhD^2*, Lindsay Gurska, PhD^2*, Emily Zyborowicz, MPH^2*, Shelby Sullivan, PharmD^2*, Jeffrey Carter, PhD^2* and Cherilyn Heggen, PhD^2*

¹Hematology Oncology of Indiana, Indianapolis, IN
²PRIME Education, New York, NY

Nora Balas, PhD^1*, Joshua Richman^2*, Wendy Landier, PhD^3*, Sadeep Shrestha, PhD^4*, Katia J Bruxvoort, PhD^5*, Lindsey Hageman, MPH^1*, Qingrui Meng, MS^3*, Elizabeth Ross^5*, Alysia Bosworth, BA^6*, Hok Sreng Te^7*, F. Lennie Wong, PhD⁸, Ravi Bhatia, MD⁹, Stephen J. Forman, MD, FACP¹⁰, Saro Armenian, DO, MPH⁶, Daniel Weisdorf, MD⁷ and Smita Bhatia, MD, MPH¹

¹Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
²Department of Surgery, University of Alabama at Birmingham, Birmingham, AL
³University of Alabama At Birmingham, Birmingham, AL
⁴School of Public Health, University of Alabama at Birmingham, Birmingham, AL
⁵University of Alabama at Birmingham, Birmingham, AL
⁶City of Hope National Medical Center, Duarte, CA
⁷University of Minnesota, Minneapolis, MN
⁸City of Hope, Duarte, CA
⁹Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
¹⁰Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

Veit L. Buecklein, MD^1*, Francis A. Ayuk, M.D.^2*, Tobias A.W. Holderried, MD^3*, Christine Mai, MD^4*, Bradley Kievit, MSc, MPH^5*, Rob Blisset, EngD^5*, Brett Doble, PhD^6*, Geoff Reid^7*, Laura Reimeir, MD^8*, Caroline Bruns, PhD^8* and Sachin Vadgama^7*

¹Department of Medicine III, LMU University Hospital, Munich, Germany
²Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
³Universitaetsklinikum Bonn (UKB), Bonn, Germany
⁴AplusA, Lyon, France
⁵Maple Health Group, LLC, New York, NY
⁶Kite, a Gilead Company, Santa Monica, CA
⁷Kite, A Gilead Company, Santa Monica, CA
⁸Gilead Sciences GmbH, Munich, Germany

Helen Ma, MD^1,2, Sameer A. Parikh, MBBS³, Roberta Santos Azevedo^4*, Susan M. O'Brien², Pankaj Gupta, MD^5* and Alessandra Ferrajoli, MD⁴

¹VA Long Beach Health System, University of California, Irvine, Long Beach, CA
²Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵VA Long Beach Healthcare System, Long Beach, CA

Andres Noyola-Perez, MD¹, Gabriel Cojuc-Konigsberg, MD^2*, Andres Gomez-De Leon, MD³ and Luis Enrique Malpica Castillo, MD⁴

¹Hematology Department, Universidad Autonoma de Nuevo Leon (UANL). Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Monterrey, Mexico
²Beth Israel Deaconess Medical Center, Boston, MA
³Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, Mexico
⁴Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Ishita Kamboj^1,2*, Jordan Snyder, PharmD^2,3*, Chelsea Gorsline^4*, Dilek Ince, MD^5*, Aneela Majeed, MD^6*, Faiz Anwer, MD^2,7, Hira Shaikh, MD^2,8, Abdullah Mohammad Khan, MD, MBBS^2,9, Al-Ola Abdallah, MD^2,10, Kimberly M Green, DO^2,11*, Shebli Atrash, MD^2,12, Claire Yun Kyoung Ryu Tiger, MD^2,13*, Prerna Mewawalla^2,14*, Barry Paul, MD, MS^2,15 and Nausheen Ahmed, MD^2,16

¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, KANSAS CITY, MO
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Overland Park, KS
⁴Division of Infectious Diseases, University of Kansas Medical Center (KUMC), KANSAS CITY, KS
⁵Division of Infectious Diseases, University of Iowa, Iowa city, IA
⁶Division of Infectious Disease, Cleveland Clinic, Cleveland, OH
⁷Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁸Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁹Division of Hematology, The Ohio State University, Columbus, OH
¹⁰Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹¹Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
¹²Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
¹³Rutgers Cancer Institute, New Brunswick, NJ
¹⁴Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA
¹⁵Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
¹⁶University of Kansas Cancer Center, Kansas City, KS

Daniel J. Olivieri, MD¹, Ajay K. Gopal, MD^2,3 and Manoj P. Menon, MD MPH^2,3*

¹Department of Medicine, University of Washington, Seattle, WA
²Division of Hematology and Oncology, University of Washington, Seattle, WA
³Fred Hutchinson Cancer Center, Seattle, WA

Kishan A Bhatt, MPA^1*, David M. DeStephano, MPH^2*, Rhea K Khurana, MPH^3*, Claire Sathe, MD, JD^4*, Seda S. Tolu, MD⁵, Hua-Jay J. Cherng, MD^6*, Jennifer E. Amengual, MD⁷, Barbara Pro, MD⁸, Dawn L Hershman, MD, MS, FASCO^9*, Justine M. Kahn, MD, MSc¹⁰ and Melissa P Beauchemin, PhD, RN, CPNP-PC^11*

¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY
²Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
³Columbia University School of Nursing, New York, NY
⁴New York Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY
⁵Division of Hematology & Oncology, Columbia University Irving Medical Center, New York City, NY
⁶Columbia University Irving Medical Center, New York, NY
⁷Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
⁸Lymphoma Program, Division of Hematology & Oncology, Columbia University, New York, NY
⁹Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
¹⁰Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY
¹¹Division of Scholarship & Research, Columbia University School of Nursing, New York, NY

Leena Chhun, BS, BA^1*, Dmytro Assonov, MD, PhD^2*, Jennifer Wren, BS^1*, Cheng Zheng, BS^1*, Jayne Piboonvaranggoon^1*, Brianna Stumph^1*, Kati O'Brien, BA^1*, Caroline Merillat^3*, Jessica Faucheaux^3*, Sophia Essiet^3*, Tara Graff, DO^4*, Patrick M. Travis, MD^5*, Sibel Blau, MD^6*, Caleb J Scheckel, DO^7*, Frank Mark Senecal, MD⁸, Ayed Ayed, MD⁹, Mehdi M. Moezi, MD¹⁰, Shannon Altimari^11*, Brian Decker^12*, Robert McCroskey, MD¹, Jaime Miller, MD^1*, Mark Walker, PhD^13* and C. Anthony Blau, MD¹

¹All4Cure, Seattle, WA
²Dmytro Assonov Consulting, Kyiv, Ukraine
³Exigent Research, Tacoma, WA
⁴Mission Cancer and Blood, Des Moines, IA
⁵HIGHLANDS ONCOLOGY GROUP PA, Rogers, AR
⁶ONCare Alliance, Seattle, WA
⁷Oklahoma Cancer Specialists and Research Institute, Tulsa, OK
⁸Northwest Medical Specialties, Tacoma, WA
⁹Cancer Specialists of North Florida, Jacksonville, FL
¹⁰Cancer Specialists of North Florida, Fleming Island, FL
¹¹GSK, Baar, Switzerland
¹²Electronic Medical Office Logistics (EMOL Health), Royal Oak, MI
¹³Walker Research Consulting, Germantown, TN

Marie Michele Sainvil, MD^1,2, Melissa Lowe, MS^3*, Delaney Underwood, MS^4*, Yan Li, PhD^3*, Tomi F. Akinyemiju, PhD, MS.^1,5*, Taewoong Choi, MD^1,2, Cristina Gasparetto, MD^1,2*, Mitchell Horwitz, MD^1,2, Gwynn D. Long, MD^1,2*, Richard Lopez, MD^1,2*, Stefanie Sarantopoulos, MD, PhD^1,2, Edwin Alyea III, MD^1,2*, Nelson J. Chao, MD^1,2, Thomas W. LeBlanc, MD, MA, MS^1,2,5, Yubin Kang, MD^1,2, Suzanne Kirby, MD, PhD^1,2, Chenyu Lin, MD^1,2, Matthew Stuart McKinney, MD^1,2, Alexandra Stefanovic, MD^1,2, Jie Wang, MD, MS^1,2, Andrea Sitlinger, MD^1,2*, Sendhilnathan Ramalingam, MD², Anthony D. Sung, MD⁶ and Sanghee Hong, MD^1,2

¹Duke Cancer Institute, Duke University School of Medicine, Durham, NC
²Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
³Duke Cancer Institute Biostatistics Shared Resource, Duke University, Durham, NC
⁴Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham
⁵Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
⁶Division of Hematologic Malignancies and Cellular Therapy, Kansas University, Kansas City, KS

Fathima Shehnaz Ayoobkhan, MD^1,2, Sara Shatnawi, MD^3,4*, Moazzam Shahzad, MD^2,5,6, Aqeeb Ur Rehman, MD^2,7*, Sohaib Irfan, MD^8,9*, Raabia Qureshi^9,10*, Arooq Khalid^9,11*, Sibgha Gull Chaudhary, MD^3,12,13*, Faiz Anwer, MD^3,14, Briha Ansari^15*, Joseph P. McGuirk, DO^3,16, Mohamad Mohty, MD, PhD^17,18,19, Nausheen Ahmed, MD²⁰, Al-Ola Abdallah, MD^3,21 and Muhammad Umair Mushtaq, MD^3,22

¹Trinity Health Oakland, Pontiac, MI
²U.S. Myeloma Innovations Research Collaborative., kansas
³US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
⁴Jordan University of Science & Technology, Irbid, Jordan
⁵University of South Florida, Division of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL
⁶H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁷University of Alabama at Birmingham, Alabama, AL
⁸Aga Khan University, Karachi, Pakistan
⁹U.S. Myeloma Innovations Research Collaborative., Kansas
¹⁰University of Missouri Medical Center, Kansas
¹¹University of Kansas Medical Center, Westwood, KS, Kansas
¹²Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
¹³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹⁴Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
¹⁵Johns Hopkins University, Baltimore
¹⁶University of Kansas Medical Center, Westwood, KS
¹⁷Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
¹⁸Hematology Department, Hôpital Saint Antoine, Service d'Hématologie Thérapie Cellulaire, Paris, France
¹⁹Saint-Antoine Research Centre, Paris, France
²⁰Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
²¹Westwood, KS
²²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Overland Park, KS

Benjamin A Derman, MD¹, James H Essell, MD², Michael A. Kolodziej, MD^3*, Lavi Kwiatkowsky^3*, Geoffrey Calkins^3*, Christina M Parrinello, PhD, MPH^4* and Mustafa S Ascha, PhD^3*

¹Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL
²Oncology/Hematology Care, Cincinnati, OH
³Canopy Care, New York City, NY
⁴Pine Mountain Consulting, New York City

Tyler B. Sandahl, PharmD^1*, Jenna Puttkammer, PharmD^1*, Chelsee J. Jensen, PharmD^1*, Adrienne N. Nedved, PharmD^1*, Justine Wilson-Miller, PharmD^1*, Kristin Cole, MS^1*, Lucy Holmes, ANP^2*, Allison Kosobud, PA-C^2*, Prashant Kapoor, MD³, Morie A. Gertz, MD², David Dingli, MD, PhD⁴, Wilson I. Gonsalves, MD², Shaji Kumar, MD⁴, Suzanne R Hayman, MD², Taxiarchis Kourelis, MD⁴, Rahma M Warsame, MD⁴, Moritz Binder, MD⁴, Joselle Cook, MBBS², Yi Lin, MD, PhD⁴ and Jason Barreto, PharmD¹

¹Department of Pharmacy, Mayo Clinic, Rochester, MN
²Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
³Mayo Clinic, Rochester, MN
⁴Division of Hematology, Mayo Clinic, Rochester, MN

So Yeon Park^1,2*, Seung Ah Yahng, MD, PhD^2,3*, Ka Young Kim, MD^1,2*, Heejoo Koh^4,5*, Seunghoon Han^5*, Seoree Kim^2,6*, Jung Yeon Lee^1,2*, Youngwoo Jeon, MD, PhD^2,7, Seung-Hwan Shin^2,8*, Chang-Ki Min^1,2* and Sung-Soo Park, MD, PhD^1,2*

¹Department of Hematology, Seoul St. Mary’s Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
²Catholic Research Network for Multiple Myeloma, Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
³Department of Hematology, Incheon St. Mary's Hospital, the Catholic University of Korea, Incheon, South Korea
⁴Department of Pharmacology, College of Medicine, The Catholic University of Kore, Seoul, KOR
⁵AIMS BioScience Co., Ltd, Seongnam-si, Korea, Republic of (South)
⁶Division of Hemato-oncology, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea, Republic of (South)
⁷Lymphoma and Cell therapy-Research Center, Yeouido ST. Mary`s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁸Department of Hematology, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)